The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence ...

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a new initiative to significantly reduce, refine, and replace animal testing ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

Please provide your email address to receive an email when new articles are posted on . The FDA issued draft guidance that would streamline testing of biosimilars. A separate plan would eliminate ...

Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System, a self-contained instrument that cultures, ...

BRONX, N.Y., Oct. 17, 2025 /PRNewswire/ -- Montefiore Einstein and Dandelion Health, Inc. ("Dandelion") have announced a strategic partnership to advance their ability to foster clinical care and drug ...

Sutter Hill Ventures-led round will accelerate drug pipeline development and advance commercialization efforts, bringing science a step closer to targeting aging REDWOOD CITY, Calif.--(BUSINESS WIRE)- ...

Creative Bioarray is dedicated to accelerating the research in clinical trials, biomarker development and testing, or drug discovery support. Recently, Creative Bioarray announced the release of its ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

The MarketWatch News Department was not involved in the creation of this content. BRONX, N.Y., Oct. 17, 2025 /PRNewswire/ -- Montefiore Einstein and Dandelion Health, Inc. ("Dandelion") have announced ...